Dr. Seder received his BA degree from Johns Hopkins University in 1981, his MD degree from Tufts University in 1986, and he completed his residency in Internal Medicine at New York Hospital-Cornell Medical Center in 1989. From 1989-1993, he received postdoctoral training in the Laboratory of Immunology at the National Institute for Allergy and Infectious Diseases (NIAID) under Dr. William Paul studying how cytokines influence CD4+ T helper cell differentiation. He then became the Chief of the Clinical Immunology Section in the Laboratory of Clinical Investigation, NIAID, in 1994, before being appointed as Chief of the Cellular Immunology Section in the Vaccine Research Center (VRC) in 2000. At the VRC, Dr. Seder has focused his work on the cellular and molecular mechanisms by which vaccine formulations, adjuvants and delivery influence protective T cell immunity in mouse and non-human primate (NHP) models of HIV, Malaria, Tuberculosis and therapeutic cancer vaccines. Dr. Seder has translated his work in malaria vaccines leading a number of Phase I/II efficacy trials has plans for moving a TB vaccine forward into Phase I testing. In addition to these vaccine efforts, Dr. Seder will assess whether passive immunization with a recently discovered monoclonal antibody against PfCSP can prevent malaria infection.